Ocular Therapeutix Inc (OCUL) earnings · rev $52.0M
These earnings events as JSON? API free 100/dayOcular Therapeutix Inc (OCUL) is a biotechnology company listed on US.
This OCUL earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported OCUL revenue for 2025-12-31 was $52.0M. Net income was -$265.9M. Revenue was down 18.5% from 2024-12-31 to 2025-12-31. OCUL currently screens at market cap $1.76B.
When the next OCUL 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 18.5% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full OCUL research stays on the stock page; the tape stays on the quote page.
OCUL earnings FAQ
What are OCUL's latest revenue and net income?
Latest cached Ocular Therapeutix Inc (OCUL) revenue for Dec 31, 2025 was $52.0M. Net income was -$265.9M. Statements: https://lician.com/financials/ocul
What is OCUL's latest diluted EPS?
Latest cached Ocular Therapeutix Inc (OCUL) diluted EPS for Dec 31, 2025 was -$1.42.
What period does the latest OCUL earnings print cover?
The latest cached Ocular Therapeutix Inc (OCUL) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did OCUL revenue change from the prior cached period?
Cached Ocular Therapeutix Inc (OCUL) revenue was down 18.5% from $63.7M (Dec 31, 2024) to $52.0M (Dec 31, 2025). Statements: https://lician.com/financials/ocul
Where are OCUL earnings listed?
Cached earnings facts for Ocular Therapeutix Inc (OCUL) are listed at https://lician.com/earnings/ocul. Statements: https://lician.com/financials/ocul
Not investment advice.